176 related articles for article (PubMed ID: 1848407)
1. Diabetes reduces heparin- and phospholipase C-releasable lipoprotein lipase from cardiomyocytes.
Braun JE; Severson DL
Am J Physiol; 1991 Mar; 260(3 Pt 1):E477-85. PubMed ID: 1848407
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol-specific phospholipase C releases lipoprotein lipase from the heparin releasable pool in rat heart cell cultures.
Chajek-Shaul T; Halimi O; Ben-Naim M; Stein O; Stein Y
Biochim Biophys Acta; 1989 Nov; 1014(2):178-83. PubMed ID: 2554975
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not insulin.
Braun JE; Severson DL
Am J Physiol; 1992 May; 262(5 Pt 1):E663-70. PubMed ID: 1590376
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
Rodrigues B; Cam MC; Jian K; Lim F; Sambandam N; Shepherd G
Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
[TBL] [Abstract][Full Text] [Related]
5. Streptozotocin-induced diabetes enhances cardiac heparin-releasable lipoprotein lipase activity in spontaneously hypertensive rats.
Shepherd G; Cam MC; Sambandam N; Abrahani MA; Rodrigues B
Hypertension; 1998 Mar; 31(3):878-84. PubMed ID: 9495276
[TBL] [Abstract][Full Text] [Related]
6. Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
Liu L; Severson DL
Can J Physiol Pharmacol; 1995 Mar; 73(3):369-77. PubMed ID: 7648516
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cardiac myocytes with 8-(4-chlorophenylthio)-adenosine 3',5'-cyclic monophosphate, forskolin or cholera toxin does not stimulate cellular or heparin-releasable lipoprotein lipase activities.
Carroll R; Juhasz A; Severson DL
Biochem J; 1990 Sep; 270(2):391-5. PubMed ID: 2169239
[TBL] [Abstract][Full Text] [Related]
8. Regulation of lipoprotein lipase activity in cardiac myocytes from control and diabetic rat hearts by plasma lipids.
Rodrigues B; Braun JE; Spooner M; Severson DL
Can J Physiol Pharmacol; 1992 Sep; 70(9):1271-9. PubMed ID: 1493594
[TBL] [Abstract][Full Text] [Related]
9. Effect of diabetes on acid and neutral triacylglycerol lipase and on lipoprotein lipase activities in isolated myocardial cells from rat heart.
RamÃrez I; Severson DL
Biochem J; 1986 Aug; 238(1):233-8. PubMed ID: 3800935
[TBL] [Abstract][Full Text] [Related]
10. Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats.
Rodrigues B; Severson DL
Can J Physiol Pharmacol; 1993 Sep; 71(9):657-61. PubMed ID: 8313228
[TBL] [Abstract][Full Text] [Related]
11. Secretion of lipoprotein lipase from myocardial cells isolated from adult rat hearts.
Severson DL; Lee M; Carroll R
Mol Cell Biochem; 1988 Jan; 79(1):17-24. PubMed ID: 3374475
[TBL] [Abstract][Full Text] [Related]
12. Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin.
Sambandam N; Abrahani MA; St Pierre E; Al-Atar O; Cam MC; Rodrigues B
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1526-34. PubMed ID: 10364085
[TBL] [Abstract][Full Text] [Related]
13. Release of lipoprotein lipase from cardiac myocytes by low-molecular weight heparin.
Braun JE; Severson DL
Lipids; 1993 Jan; 28(1):59-61. PubMed ID: 8383273
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein lipase degradation by adipocytes: receptor-associated protein (RAP)-sensitive and proteoglycan-mediated pathways.
Obunike JC; Sivaram P; Paka L; Low MG; Goldberg IJ
J Lipid Res; 1996 Nov; 37(11):2439-49. PubMed ID: 8978495
[TBL] [Abstract][Full Text] [Related]
15. Acute intralipid infusion reduces cardiac luminal lipoprotein lipase but recruits additional enzyme from cardiomyocytes.
Qi D; Kuo KH; Abrahani A; An D; Qi Y; Heung J; Kewalramani G; Pulinilkunnil T; Ghosh S; Innis SM; Rodrigues B
Cardiovasc Res; 2006 Oct; 72(1):124-33. PubMed ID: 16934788
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein lipase activity is stimulated by insulin and dexamethasone in cardiomyocytes from diabetic rats.
Ewart HS; Carroll R; Severson DL
Can J Physiol Pharmacol; 1999 Aug; 77(8):571-8. PubMed ID: 10543720
[TBL] [Abstract][Full Text] [Related]
17. Post-transcriptional mechanisms are responsible for the reduction in lipoprotein lipase activity in cardiomyocytes from diabetic rat hearts.
Carroll R; Liu L; Severson DL
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):67-72. PubMed ID: 7646474
[TBL] [Abstract][Full Text] [Related]
18. Long term incubation of cardiac myocytes with oleic acid and very-low density lipoprotein reduces heparin-releasable lipoprotein lipase activity.
Rodrigues B; Spooner MR; Severson DL
Mol Cell Biochem; 1992 Oct; 116(1-2):33-7. PubMed ID: 1480152
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of adipocyte heparan sulfate proteoglycans with affinity for lipoprotein lipase.
Misra KB; Kim KC; Cho S; Low MG; Bensadoun A
J Biol Chem; 1994 Sep; 269(38):23838-44. PubMed ID: 8089154
[TBL] [Abstract][Full Text] [Related]
20. Effect of taxol on the heparin-induced secretion of lipoprotein lipase from cardiac myocytes.
Severson DL; Carroll R
Mol Cell Biochem; 1989 Jun 27-Jul 24; 88(1-2):17-22. PubMed ID: 2571074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
